Bipolar disorder, also known as manic depression, is a mental disorder that could lead to periods of depression and elevated mood. The treatment of bipolar disorder includes psychotherapy as well as medications such as mood stabilizers and antipsychotics.

The global Bipolar Disorder Drugs market was valued at xx million US$ in 2018 and will reach xx million US$ by the end of 2025, growing at a CAGR of xx% during 2019-2025.
This report focuses on Bipolar Disorder Drugs volume and value at global level, regional level and company level. From a global perspective, this report represents overall Bipolar Disorder Drugs market size by analyzing historical data and future prospect.
Regionally, this report categorizes the production, apparent consumption, export and import of Bipolar Disorder Drugs in North America, Europe, China, Japan, Southeast Asia and India.
For each manufacturer covered, this report analyzes their Bipolar Disorder Drugs manufacturing sites, capacity, production, ex-factory price, revenue and market share in global market.

The following manufacturers are covered:
AstraZeneca
Bristol-Myers Squibb Company
Eli Lilly
Astellas Pharma
Allergan
Johnson & Johnson.
GlaxoSmithKline
AbbVie
Pfizer
Novartis

Segment by Regions
North America
Europe
China
Japan
Southeast Asia
India

Segment by Type
Mood Stabilizers
Antipsychotic Drugs
Antidepressant Drugs
Other Drugs

Segment by Application
Hospital
Lab
Others